SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Nestle Health Science US Holdings, Inc., et al. – ‘3’ for 5/8/19 re: Axcella Health Inc.

On:  Friday, 2/14/20, at 4:50pm ET   ·   For:  5/8/19   ·   Accession #:  899243-20-4662   ·   File #:  1-38901

Previous ‘3’:  ‘3’ on / for 11/23/16   ·   Next & Latest:  ‘3’ on 4/24/20 for 12/31/18

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/14/20  Nestle Health Science US Hol… Inc 3                      1:10K  Axcella Health Inc.               Donnelley Fin’l S… 06/FA
          Societe des Produits Nestle S.A.
          Nestle US Holdco, Inc.
          Nestle SA
          NIMCO US, Inc.

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Form 3 Submission -- doc3.xml/2.6                   HTML      3K 




        

This ‘3’ Document is an XML Data File that may be rendered in various formats:

  Form 3    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Form 3 Submission
 
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Nestle Health Science US Holdings, Inc.

(Last)(First)(Middle)
1812 NORTH MOORE STREET

(Street)
ARLINGTONVA22209

(City)(State)(Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
5/8/19
3. Issuer Name and Ticker or Trading Symbol
Axcella Health Inc. [ AXLA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock2,368,699ISee Footnote (1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Nestle Health Science US Holdings, Inc.

(Last)(First)(Middle)
1812 NORTH MOORE STREET

(Street)
ARLINGTONVA22209

(City)(State)(Zip)
1. Name and Address of Reporting Person*
Societe des Produits Nestle S.A.

(Last)(First)(Middle)
AVENUE NESTLE 55, CH-1800

(Street)
VEVEYV8

(City)(State)(Zip)
1. Name and Address of Reporting Person*
Nestle US Holdco, Inc.

(Last)(First)(Middle)
1812 NORTH MOORE STREET

(Street)
ARLINGTON22209

(City)(State)(Zip)
1. Name and Address of Reporting Person*
NESTLE SA

(Last)(First)(Middle)
AVENUE NESTLE 55, CH-1800

(Street)
VEVEY

(City)(State)(Zip)
1. Name and Address of Reporting Person*
NIMCO US, Inc.

(Last)(First)(Middle)
1812 NORTH MOORE STREET

(Street)
ARLINGTONVA22209

(City)(State)(Zip)
Explanation of Responses:
(1)  Held by Nestle Health Science US Holdings, Inc. ("NHS"). NHS is a wholly owned subsidiary of NIMCO US, Inc. ("NIMCO"). NIMCO, in turn, is a wholly-owned subsidiary of Nestle US Holdco, Inc. ("Nestle US Holdco"), which is a wholly-owned subsidiary of Societe des Produits Nestle S.A. ("SPN"). The ultimate parent company of NHS, NIMCO, Nestle US Holdco and SPN is Nestle S.A. ("Nestle"), a publicly traded company. Each of these entities may be deemed to share voting and investment power with respect to all shares of Common Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Common Stock except to the extent of its pecuniary interest therein.
Remarks:
This Form 3 is being filed late due to administrative oversight.
NESTLE HEALTH SCIENCE US HOLDINGS, INC. By: Name: James Pepin, Title: Director and President 2/12/20
NIMCO US, INC. By: Name: Dan Nugent, Title: Chief Legal Officer and General Counsel 2/12/20
NESTLE US HOLDCO, INC. By: Name: Michael Prewitt, Title: Secretary 2/12/20
SOCIETE DES PRODUITS NESTLE S.A. By: Name: Claudio Kuoni, Title: Vice President 2/12/20
NESTLE S.A. By: Name: Gregory Behar, Title: Deputy Executive Vice President 2/12/20
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Top
Filing Submission 0000899243-20-004662   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 3:56:27.1am ET